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To the Editor:
We read with interest the paper by Kamath et al.1) on the 
efficacy of saline-coupled bipolar sealing devices in simul-
taneous bilateral total knee arthroplasty (TKA). The use of 
bipolar sealing and conventional electrocautery was com-
pared in 71 consecutive patients who underwent bilateral 
TKA. Unfortunately, it must be noted that there are dis-
crepancies in the reported transfusion rates. It was stated 
in the results section of the abstract that patients treated 
with the bipolar sealer were 35% less likely to require a 
transfusion when compared with patients treated with 
conventional electrocautery. The same percentage (35%) 
was presented in the conclusion section of the article. In 
contrast, the authors state that in their discussion that the 
blood transfusion rates were 33% lower in the experimen-
tal bilateral group when compared with the control group. 
The results section of the article and Table 2 claim that 55% 
(16 of 29) of patients in the experimental cohort required a 
blood transfusion, while the rate was 83% (35 of 42) in the 
control group. Therefore, the difference in transfusion re-
quirements between the two groups would be 28% and not 
the 35% or 33% stated elsewhere in the paper.
The need for blood transfusion was determined in 
the study based upon clinical need as determined by the 
surgeon and medical co-management team. This included 
consideration of pertinent medical comorbidities (e.g., 
strong history of cardiac disease), clinical symptoms such 
as lethargy, and hemodynamic parameters such as tachy-
cardia and/or hypotension refractory to initial fluid resus-
citation. In general, patients without cardiac history were 
not transfused for a haemoglobin level greater than 8 g/dL. 
Fixed, predetermined transfusion triggers were not em-
ployed, allowing the need for transfusion to appear vague 
in nature. As stated as a limitation, the staff and surgeons 
were not blinded and therefore there was a possibility of 
bias in the decision making process but the authors state 
that the criteria for transfusing symptomatic patients was 
used consistently.
It is interesting to note that patients who were treat-
ed with the bipolar sealing device when compared with 
patients in the control group had: matched demographics, 
similar preadmission haemoglobin level (13.5 g/dL vs. 13.3 
g/dL), similar estimated blood loss (100 mL) and nonsig-
nificant increased haemoglobin decline (4.2 g/dL vs. 4.8 
g/dL), yet finished with the significantly less transfusion 
requirements.1) It is unclear why there should be a signifi-
cant difference in transfusion rates when other parameters 
were similar. One potential explanation for this could be 
age. It is known that transfusion requirement after major 
joint arthroplasty is greater in the elderly.2) We note that 
the control group probably contained a greater number 
of more elderly patients compared with the experimental 
group (63.4 ± 17.9 vs. 59.1 ± 4.1), and it would be interest-
ing to know the ages of those that required transfusions as 
a possible explanation to account for the differences be-
tween the two groups. Another possible explanation could 
be the contribution of dilutional anaemia, and it would be 
useful to know if there were any differences in the periop-
erative use of intravenous fluid between the two groups.
The overall transfusion requirements found in this 
study are different to those experienced in our clinical 
practice. An analysis of bilateral TKA performed at our 
institution is presented in Table 1. A saline-coupled bi-
polar sealing device was not used in any of the cases. Our 
centre employs a fairly restrictive transfusion policy and is 
governed by a team of senior intensive care specialists who 
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work as perioperative physicians. In general, transfusion 
is avoided in patients with a haemoglobin level > 8 g/dL 
and used in all patients with a haemoglobin level < 6 g/dL. 
For those in between, the decision to transfuse is based 
on patient factors such as comorbidity and cardiorespira-
tory risk, ongoing blood loss, and symptoms related to 
anaemia. Haemoglobin levels between 8–10 g/dL, but who 
experience symptomatic anaemia despite an adequate cir-
culatory volume. The transfusion protocol is similar to the 
protocol presented in the Levine et al.3)
Our transfusion rate was much lower at 17% com-
pared with 55% and 83% rates reported by Kamath et al.1) 
respectively (Table 1). Whilst stringent parameters are 
at odds with an individual patients needs based on the 
clinical picture, it would seem prudent that studies which 
use transfusion rates as the primary outcome should set 
fixed parameters. In cases where the parameters were not 
followed due to clinical need, a summary of indications 
could be included which would allow a clearer picture and 
explain results such as those found by Kamath et al.1)
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Table 1. Preoperative Patient Characteristics and Perioperative Haemodynamic Values* 
Variable SWLEOC (n = 36)
Kamath et al.1)
Control group (n = 42) Bipolar sealer group (n = 29)
Age (yr)† 69.9 ± 2.8 63.4 ± 17.9 59.1 ± 4.1
Body mass index (kg/m2)‡  31.0 (32.0–27.0)  32.4 (29.2–38.9)  35.0 (31.4–42.9)
ASA classification§   2.0 ± 0.38 2.58 ± 0.55 2.59 ± 0.5
Male sex     17 (47.2%)     16 (38%)     14 (48%)
Preadmission haemoglobin (g/dL)† 13.8 ± 3.7 13.3 ± 0.5 13.5 ± 0.4
Transfusion required       6 (17%)     35 (83%)     16 (55%)
Units of blood transfused‡       0 (0–0)       2 (2–2)       1 (0–2)
> 2 Units of blood transfused       2 (6%)       8 (19%)       2 (6.9%)
Estimated blood loss (mL)‡,ΙΙ     50 (50–100)   100 (42.5–150)   100 (75–200)
Discharge haemoglobin (g/dL)‡  10.1 (9.6–10.9)    9.4 (8.7–10.1)    9.1 (8.7–9.4)
Haemoglobin decline (g/dL)†   3.4 ± 4.0   4.2 ± 0.5   4.8 ± 0.4
Operative time (min)† 154.1 ± 10.5  174 ± 8.7  196 ± 15.5
The table is displayed with the same units and descriptive statistics as the original paper. 
ASA: American Society of Anesthesiologists, SWLEOC: South West London Elective Orthopaedic Centre.
*The values of patients who underwent bilateral total knee arthroplasty under the care of five surgeons at the SWLEOC over 2-year period (2014.6.1–2016.5.31).
Values are presented as †mean ± 95% confidence interval, ‡median (interquartile range), §mean ± standard deviation.
ΙΙIntraoperative blood loss is reported as categorical values (minimal, < 100 mL, < 200 mL, < 500 mL). The upper limits were used for calculation and the minimal 
category was given a value of 50 mL for calculation.
